Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy SIGA Technologies stock | $6.99

Own SIGA Technologies stock in just a few minutes.

Fact checked

SIGA Technologies, Inc is a biotechnology business based in the US. SIGA Technologies shares (SIGA) are listed on the NASDAQ and all prices are listed in US Dollars. SIGA Technologies employs 41 staff and has a trailing 12-month revenue of around USD$91.5 million.

How to buy shares in SIGA Technologies

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for SIGA Technologies. Find the stock by name or ticker symbol: SIGA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until SIGA Technologies reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$6.99, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of SIGA Technologies, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of SIGA Technologies. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

SIGA Technologies share price

Use our graph to track the performance of SIGA stocks over time.

SIGA Technologies shares at a glance

Information last updated 2020-12-09.
Latest market closeUSD$6.99
52-week rangeUSD$3.96 - USD$7.85
50-day moving average USD$7.0274
200-day moving average USD$6.7017
Wall St. target priceUSD$11
PE ratio 18.0879
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.387

Buy SIGA Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy SIGA Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

SIGA Technologies price performance over time

Historical closes compared with the close of $6.99 from 2020-12-09

1 week (2021-01-08) -8.63%
1 month (2020-12-15) -0.85%
3 months (2020-10-15) 3.25%
6 months (2020-07-15) 12.20%
1 year (2020-01-15) 33.91%
2 years (2019-01-15) -5.41%
3 years (2018-01-15) N/A
5 years (2016-01-15) 1,206.54%

Is SIGA Technologies under- or over-valued?

Valuing SIGA Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SIGA Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

SIGA Technologies's P/E ratio

SIGA Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, SIGA Technologies shares trade at around 18x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

SIGA Technologies's EBITDA

SIGA Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$54.8 million.

The EBITDA is a measure of a SIGA Technologies's overall financial performance and is widely used to measure a its profitability.

SIGA Technologies financials

Revenue TTM USD$91.5 million
Operating margin TTM 59.27%
Gross profit TTM USD$10.9 million
Return on assets TTM 19.68%
Return on equity TTM 29.35%
Profit margin 34.62%
Book value $1.452
Market capitalisation USD$541.8 million

TTM: trailing 12 months

Shorting SIGA Technologies shares

There are currently 2.5 million SIGA Technologies shares held short by investors – that's known as SIGA Technologies's "short interest". This figure is 2.8% down from 2.6 million last month.

There are a few different ways that this level of interest in shorting SIGA Technologies shares can be evaluated.

SIGA Technologies's "short interest ratio" (SIR)

SIGA Technologies's "short interest ratio" (SIR) is the quantity of SIGA Technologies shares currently shorted divided by the average quantity of SIGA Technologies shares traded daily (recently around 208870.42606516). SIGA Technologies's SIR currently stands at 11.97. In other words for every 100,000 SIGA Technologies shares traded daily on the market, roughly 11970 shares are currently held short.

However SIGA Technologies's short interest can also be evaluated against the total number of SIGA Technologies shares, or, against the total number of tradable SIGA Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SIGA Technologies's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 SIGA Technologies shares in existence, roughly 30 shares are currently held short) or 0.0497% of the tradable shares (for every 100,000 tradable SIGA Technologies shares, roughly 50 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against SIGA Technologies.

Find out more about how you can short SIGA Technologies stock.

SIGA Technologies share dividends

We're not expecting SIGA Technologies to pay a dividend over the next 12 months.

SIGA Technologies share price volatility

Over the last 12 months, SIGA Technologies's shares have ranged in value from as little as $3.96 up to $7.85. A popular way to gauge a stock's volatility is its "beta".

SIGA.US volatility(beta: 0.64)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SIGA Technologies's is 0.6388. This would suggest that SIGA Technologies's shares are less volatile than average (for this exchange).

SIGA Technologies overview

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site